Aandelen in “Biotechnologie”
Aandeel | Datum | Koers | Evolutie |
---|---|---|---|
C4 Therapeutics Inc | 10/01 | 3,665 USD
-4,56% |
-4,56% |
Cabaletta Bio Inc | 10/01 | 2,075 USD
-10,56% |
-10,56% |
Calithera Biosciences Inc | 9/01 | 0,000 USD
0,00% |
0,00% |
Can-Fite Biopharma Ltd | 10/01 | 1,580 USD
+0,64% |
+0,64% |
Capricor Therapeutics Inc | 10/01 | 13,190 USD
-4,83% |
-4,83% |
Cara Therapeutics Inc | 10/01 | 4,750 USD
0,00% |
0,00% |
Carbios | 9/01 | 6,610 EUR
+0,15% |
+0,15% |
Carisma Therapeutics, Inc. | 10/01 | 0,471 USD
-0,61% |
-0,61% |
CASI Pharmaceuticals Inc | 10/01 | 2,610 USD
-8,74% |
-8,74% |
Cel-Sci Corp. | 10/01 | 0,425 USD
+16,05% |
+16,05% |
Celldex Therapeutics Inc. | 10/01 | 24,350 USD
-8,22% |
-8,22% |
Cellectar Biosciences Inc | 10/01 | 0,282 USD
-9,23% |
-9,23% |
Cellectis | 10/01 | 1,850 USD
-4,15% |
-4,15% |
Cellectis | 10/01 | 1,782 EUR
+0,56% |
+0,56% |
Celyad Oncology | 9/01 | 0,584 EUR
-2,34% |
-2,34% |
Champions Oncology Inc | 10/01 | 9,470 USD
-1,97% |
-1,97% |
Chimerix Inc | 10/01 | 3,250 USD
-6,88% |
-6,88% |
Cidara Therapeutics Inc | 10/01 | 24,000 USD
-3,54% |
-3,54% |
Co-Diagnostics Inc | 10/01 | 0,830 USD
+7,05% |
+7,05% |
Cogent Biosciences Inc | 10/01 | 7,840 USD
-3,33% |
-3,33% |
CohBar Inc | 6/01 | 0,410 USD
0,00% |
0,00% |
Coherus Biosciences Inc | 10/01 | 1,470 USD
-2,65% |
-2,65% |
CollPlant Biotechnologies Ltd | 10/01 | 4,198 USD
-3,87% |
-3,87% |
Compass Pathways Plc | 10/01 | 3,530 USD
-14,73% |
-14,73% |
Compugen Ltd. | 10/01 | 1,640 USD
+3,14% |
+3,14% |
Corbus Pharmaceuticals Holdings Inc | 10/01 | 11,790 USD
-5,23% |
-5,23% |
CRISPR Therapeutics AG | 10/01 | 39,690 USD
-3,88% |
-3,88% |
Cue Biopharma Inc | 10/01 | 1,510 USD
+4,14% |
+4,14% |
Curis Inc | 10/01 | 3,390 USD
-2,02% |
-2,02% |
Cyclacel Pharmaceuticals Inc | 10/01 | 0,420 USD
+1,21% |
+1,21% |
Cyclacel Pharmaceuticals Inc | 10/01 | 7,600 USD
-3,55% |
-3,55% |
Cytokinetics Inc | 10/01 | 46,620 USD
-1,58% |
-1,58% |
CytomX Therapeutics Inc | 10/01 | 0,880 USD
-10,45% |
-10,45% |
Cytotools AG | 8/01 | 1,210 EUR
-4,35% |
-4,35% |